Tohoku University Tohoku Medical Megabank Organization (Ritsuko Shimizu)
2020.11.20

1.   Suzuki Takafumi, Uruno Akira, Yumoto Akane, et al. Nrf2 contributes to the weight gain of mice during space travel. Communications Biology. 2020; 3 (1): 496. doi:10.1038/s42003-020-01227-2  
2.   Kuriyama Shinichi, Metoki Hirohito, Kikuya Masahiro, et al. Cohort Profile: Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study (TMM BirThree Cohort Study): rationale, progress and perspective. International Journal of Epidemiology. 2020; 49 (1): 18-19m. doi:10.1093/ije/dyz169  
3.   Shimizu Ritsuko, Yamamoto Masayuki. Quantitative and qualitative impairments in GATA2 and myeloid neoplasms. IUBMB Life. 2020; 72 (1): 142-150. doi:10.1002/iub.2188  
4.   Hozawa Atsushi, Tanno Kozo, Nakaya Naoki, et al. Study Profile of the Tohoku Medical Megabank Community-Based Cohort Study. Journal of Epidemiology. 2020; : . doi:10.2188/jea.JE20190271  
5.   Tsuboi Akito, Matsui Hiroyuki, Shiraishi Naru, et al. Design and Progress of Oral Health Examinations in the Tohoku Medical Megabank Project. The Tohoku Journal of Experimental Medicine. 2020; 251 (2): 97-115. doi:10.1620/tjem.251.97  
6.   Harada Nobuhiko, Hasegawa Atsushi, Hirano Ikuo, et al. GATA 2 hypomorphism induces chronic myelomonocytic leukemia in mice. Cancer Science. 2019; 110 (4): 1183-1193. doi:10.1111/cas.13959  
7.   Fuse Nobuo, Sakurai-Yageta Mika, Katsuoka Fumiki, et al. Establishment of Integrated Biobank for Precision Medicine and Personalized Healthcare: The Tohoku Medical Megabank Project. JMA Journal. 2019; 2 (2): 113-122. doi:10.31662/jmaj.2019-0014  
8.   Yasuda Jun, Kinoshita Kengo, Katsuoka Fumiki, et al. Genome analyses for the Tohoku Medical Megabank Project towards establishment of personalized healthcare. The Journal of Biochemistry. 2019; 165 (2): 139-158. doi:10.1093/jb/mvy096  
9.   Pan Xiaoqing, Nariai Naoki, Fukuhara Noriko, et al. Monitoring of minimal residual disease in early T‐cell precursor acute lymphoblastic leukaemia by next‐generation sequencing. British Journal of Haematology. 2017; 176 (2): 318-321. doi:10.1111/bjh.13948  
10.   Hasegawa Atsushi, Shimizu Ritsuko. GATA1 Activity Governed by Configurations of cis-Acting Elements. Frontiers in Oncology. 2017; 6 : . doi:10.3389/fonc.2016.00269  
11.   Kaneko Hiroshi, Katoh Takehide, Hirano Ikuo, et al. Induction of erythropoietin gene expression in epithelial cells by chemicals identified in GATA inhibitor screenings. Genes to Cells. 2017; 22 (11): 939-952. doi:10.1111/gtc.12537  
12.   Yu Lei, Moriguchi Takashi, Kaneko Hiroshi, et al. Reducing Inflammatory Cytokine Production from Renal Collecting Duct Cells by Inhibiting GATA2 Ameliorates Acute Kidney Injury. Molecular and Cellular Biology. 2017; 37 (22): e00211-17. doi:10.1128/MCB.00211-17  
13.   Hirano Ikuo, Suzuki Norio, Yamazaki Shun, et al. Renal Anemia Model Mouse Established by Transgenic Rescue with an Erythropoietin Gene Lacking Kidney-Specific Regulatory Elements. Molecular and Cellular Biology. 2017; 37 (4): MCB.00451-16. doi:10.1128/MCB.00451-16  
14.   Kuriyama Shinichi, Yaegashi Nobuo, Nagami Fuji, et al. The Tohoku Medical Megabank Project: Design and Mission. Journal of Epidemiology. 2016; 26 (9): 493-511. doi:10.2188/jea.JE20150268  
15.   Hasegawa Atsushi, Kaneko Hiroshi, Ishihara Daishi, et al. GATA1 Binding Kinetics on Conformation-Specific Binding Sites Elicit Differential Transcriptional Regulation. Molecular and Cellular Biology. 2016; 36 (16): 2151-2167. doi:10.1128/MCB.00017-16  
16.   Yamazaki Hiromi, Suzuki Mikiko, Otsuki Akihito, et al. A Remote GATA2 Hematopoietic Enhancer Drives Leukemogenesis in inv(3)(q21;q26) by Activating EVI1 Expression. Cancer Cell. 2014; 25 (4): 415-427. doi:10.1016/j.ccr.2014.02.008  
17.   Mishima Eikan, Inoue Chisako, Saigusa Daisuke, et al. Conformational change in transfer RNA is an early indicator of acute cellular damage. Journal of the American Society of Nephrology : JASN. 2014; 25 (10): 2316-26. doi:10.1681/ASN.2013091001  
18.   Mukai Harumi Y., Suzuki Mikiko, Nagano Masumi, et al. Establishment of erythroleukemic GAK14 cells and characterization of GATA1 N-terminal domain. Genes to Cells. 2013; 18 (10): 886-898. doi:10.1111/gtc.12084  
19.   Shimizu Ritsuko, Hasegawa Atsushi, Ottolenghi Sergio, et al. Verification of the in vivo activity of three distinct cis -acting elements within the Gata1 gene promoter-proximal enhancer in mice. Genes to Cells. 2013; 18 (11): 1032-1041. doi:10.1111/gtc.12096